Patel, J. N., Jiang, C., Hertz, D. L., Mulkey, F. A., Owzar, K., Halabi, S., Ratain, M. J., Friedman, P. N., Small, E. J., Carducci, M. A., Mahoney, J. F., Kelley, M. J., Morris, M. J., Kelly, W. K., & McLeod, H. L. (2015). bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration‐resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance). Cancer, 121(7), 1025–1031. http://access.bl.uk/ark:/81055/vdc_100025156188.0x00002c